Why Health Care Still Fails at the Moment of Truth

May 12, 2026

10 min read

8 views

84%

The uncomfortable question behind both stories

What happens when a system looks impressive on paper, but under real pressure it does not perform where it matters most? That question sits beneath both the surge of employers bypassing insurers and the sobering realization that promising AI imaging tools often fail to deliver in clinical practice.

At first glance, these seem like separate stories. One is about buyers trying to escape rising costs. The other is about technology failing to live up to its laboratory glow. But they meet at a deeper point: modern health care is full of intermediaries, models, and validations that can look efficient, elegant, and even transformative, until someone has to rely on them in the messy world of actual patients.

That is the real tension. Health care does not merely need better ideas. It needs better contact with reality.

The illusion of competence in systems built far from the bedside

A lot of broken systems survive because their weaknesses are hidden by distance. In health care, that distance can take many forms: between employer and employee, between insurer and provider, between algorithm and patient, between research study and clinical workflow.

When an employer purchases coverage through a large carrier, the arrangement can feel reassuringly complete. There is a network, a card, a premium, a plan document, and a promise. Yet what the employer is really buying is not health care itself but access to a complex administrative machine that sits between people and treatment. As prices rise, that machine starts to look less like protection and more like a toll road.

AI imaging has a similar problem. In a controlled setting, an algorithm can appear brilliant. The metrics are polished, the examples are curated, and the model may outperform on retrospective data. But once it enters a live environment, the story changes. The scanner images are noisier, the patient population is broader, the workflow is slower, and the consequences of error become immediate. A tool that seemed intelligent in a paper can feel merely brittle in practice.

The true test of any health care system is not whether it looks sophisticated under controlled conditions, but whether it improves decisions when the world gets messy.

This is why both stories are really about translation. Can an organization translate spending into value? Can an algorithm translate statistical performance into clinical usefulness? In each case, the problem is not the absence of activity. It is the failure to convert activity into trustworthy outcomes.

Why employers are bypassing the middleman

The move by employers toward direct contracting and primary care is not just a cost-cutting tactic. It is a vote of no confidence in the old model of delegated care.

For decades, employers have been told that purchasing through insurers is the rational way to manage risk. Insurers aggregate lives, negotiate rates, process claims, and promise scale. But when premiums keep climbing and the value feels hard to see, employers start asking a more fundamental question: What exactly are we paying for?

The answer, increasingly, is that they can buy some of the most important parts more directly. They can contract with doctors, hospitals, and primary care groups. They can pay clinicians to spend more time on prevention, chronic disease management, and coordination. In other words, they can spend money upstream instead of endlessly financing downstream crises.

That matters because primary care is not just a service line. It is the operating system of health care. Good primary care reduces fragmentation, catches problems early, and keeps people from bouncing through an expensive maze of specialists, duplicate tests, and avoidable admissions. If the health system is a city, primary care is not the tourist office. It is traffic control, zoning, public safety, and neighborhood mapping all at once.

The deeper insight is that employers are not simply seeking cheaper care. They are seeking more legible care. Direct relationships make it easier to see where money goes, where care fails, and what actually changes outcomes. The more visible the mechanism, the harder it is for waste to hide behind abstraction.

This is why carriers may feel pressure. If the biggest buyers begin walking away, insurers must prove they are not just a billing layer with a brand. They must become something closer to a genuine health partner. If they cannot, they risk becoming the fax machine of modern medicine: expensive to maintain, hard to fully replace at first, and increasingly irrelevant.

The AI lesson: intelligence without context is not enough

The disappointment around AI imaging is especially useful because it exposes a mistake people often make about technology: they confuse prediction with performance.

A model can be accurate in a narrow sense and still fail in a hospital. Why? Because health care is not a clean prediction contest. It is a living workflow with human judgment, time constraints, competing priorities, and ethical stakes. A radiologist does not need a model that performs beautifully in a benchmark and then forces extra steps, produces false confidence, or works only on a subset of cases.

This is where many AI projects stall. They are designed as if clinical practice were a static dataset rather than an evolving conversation. But the clinical environment is not just a place where decisions are made. It is a place where decisions are contested, revised, documented, communicated, and acted upon. Any tool that ignores that chain is not just incomplete, it is mis-specified.

A useful analogy is navigation. A map can be mathematically elegant, but if it does not account for traffic, construction, road closures, and the driver's actual destination, it is not really useful. In the same way, a diagnostic model that cannot fit into the rhythms of care may remain impressive and still be operationally useless.

That is why the phrase full diagnostic potential matters. Potential is not the same thing as readiness. A technology can be promising while still unprepared for the realities that determine value. The distance between promise and practice is where most health care innovations go to die.

The shared failure mode: proxy worship

These two stories reveal a common disease in modern institutions: proxy worship.

When organizations cannot directly measure what they truly care about, they start worshipping substitutes. In health care, those substitutes can include premiums instead of health outcomes, utilization instead of well-being, model accuracy instead of clinical utility, or vendor sophistication instead of actual trust.

Proxy worship is seductive because it creates the appearance of control. It lets leaders manage spreadsheets, dashboards, and contracts without confronting the harder question: did people get better?

Employers who bypass insurers are, in a sense, rejecting one proxy system for another, hopefully better one. Direct contracting and strengthened primary care do not guarantee success. But they reduce the number of layers between decision maker and outcome. That makes failure easier to see and improvement easier to reward.

AI medicine faces a similar challenge. If a model looks good on retrospective studies but fails in practice, the proxy was mistaken for the goal. The metric mattered, but not enough. The true measure should be whether the tool improves real decisions, at real speed, for real patients.

When a system optimizes the proxy, it may become more efficient at being wrong.

This is the heart of the connection between these stories. Both are reminders that health care often rewards structures that can describe value without reliably delivering it.

A better framework: health care needs shorter feedback loops

If there is a single principle uniting these developments, it is this: the faster a health care system learns from reality, the better it performs.

Short feedback loops matter because health care is full of delayed consequences. A poor diet becomes diabetes years later. A delayed referral becomes a hospitalization. A diagnostic false positive becomes wasted time and anxiety. A pricing arrangement looks tolerable until the premium renewal arrives. Systems that delay accountability can keep mistaking volume for value.

Primary care shortens the feedback loop by giving patients a consistent point of contact. A clinician who knows the patient can notice changes early, intervene sooner, and coordinate care before problems compound. Direct employer relationships can shorten the loop too, because buyers can observe the effects of what they purchase more quickly and more clearly.

AI tools also need shorter feedback loops. The best systems will not merely spit out predictions. They will integrate with clinical workflows in ways that show whether their suggestions were helpful, ignored, wrong, or noisy. The learning system has to include human behavior, not just image data.

Think of it this way: the difference between a mature health care system and an immature one is not whether it uses sophisticated tools. It is whether those tools are tied to consequences fast enough to improve themselves.

That suggests a practical rule for evaluating any health innovation:

How directly does it connect to the point of care?
How quickly does it reveal whether it works?
How easily can it be corrected when it does not?

The more indirect the answer, the more likely the system is trading on optimism.

What employers and health innovators can learn from each other

Employers entering direct care arrangements and AI developers trying to prove diagnostic value may seem to inhabit different worlds, but they actually face the same strategic challenge: trust must be earned at the edge, not assumed from the center.

For employers, that means moving beyond purchasing a plan and hoping the plan creates health. It means funding relationships, not just coverage. It means evaluating whether a primary care investment lowers avoidable ER use, improves chronic disease control, reduces employee friction, and creates a clearer experience. The question is not just whether the model is cheaper. It is whether it creates a tighter loop between need, response, and outcome.

For AI developers, the lesson is similar. A model should not be judged only by retrospective performance or flashy demonstrations. It should be judged by whether it improves the work of clinicians without adding confusion, delay, or hidden burden. The best AI is not the one that looks smartest in isolation. It is the one that behaves best inside the clinical ecosystem.

Both groups should ask the same uncomfortable question: What would it take for this to fail visibly?

That question is powerful because it forces honesty. If failure is easy to hide, the system is probably too abstract. If failure is visible early, the system has a chance to learn. That is a feature, not a flaw.

Key Takeaways

Prefer directness over abstraction. Whether buying care or deploying AI, systems closer to the actual point of use tend to reveal truth faster.
Treat proxies as warnings, not goals. Premiums, benchmark accuracy, and vendor claims can be informative, but they are not the same as outcomes.
Shorten the feedback loop. The sooner a system shows whether it is helping, the more likely it is to improve.
Value workflow fit as much as technical performance. A brilliant tool that slows clinicians down is not truly brilliant.
Ask what is being intermediated. If too many layers sit between decision makers and outcomes, value can vanish without anyone noticing.

The real revolution in health care is not more sophistication

It is tempting to think the future belongs to smarter insurers, more advanced AI, or better dashboards. But the deeper lesson from these developments is almost the opposite. Health care improves not when it becomes more abstract, but when it becomes more accountable to reality.

Employers are starting to notice that they can no longer afford a system that charges them for the privilege of being distant from care. AI researchers are discovering that impressive models are not enough if they cannot survive contact with clinical life. In both cases, the system is being forced to answer a brutal question: Can you produce value where the patient actually is?

That question should become the standard for every health innovation. Not, does it look promising? Not, does it scale? Not, does it satisfy a benchmark? But rather: does it shorten the distance between problem and solution, between signal and action, between illness and relief?

The future of health care may belong to those who understand this simple but difficult truth: the systems that win are not the ones that seem smartest from afar. They are the ones that stay honest at the bedside.